Pneumonia
📧 Sign up to get email alerts when something new happens for Pneumonia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: 3 Days Amoxicillin Versus Placebo for Fast Breathing Childhood Pneumonia in Malawi [Phase 4]
Phase 4 trial comparing 3 days of amoxicillin to placebo for fast-breathing pneumonia in children in Malawi has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: 3 Days Versus 5 Days Amoxicillin for Chest-indrawing Childhood Pneumonia in Malawi [Phase 4]
Phase 4 trial comparing 3 days vs 5 days of amoxicillin for chest-indrawing pneumonia in children in Malawi has completed.
-
FDA approval · 2021-02-16FDA Approved: PIPERACILLIN, TAZOBACTAM — Original Application (Sagent Pharmaceuticals)
FDA approves Sagent Pharmaceuticals' generic Piperacillin-tazobactam for intravenous use under Original Application, enabling a generic vers…
-
CLINICAL_TRIALS trial_result · 2021-02-03Clinical Trial Update: Trial to Evaluate Beta-Lactam Antimicrobial Therapy of Community Acquired Pneumonia in Children [Phase 4]
Phase 4 trial update evaluating beta-lactam antimicrobial therapy for community-acquired pneumonia in children has completed with results po…
-
CLINICAL_TRIALS trial_result · 2021-01-05Clinical Trial Update: Safety, PK and PD of Kamada Anti-SARS-CoV-2 in COVID-19 [Phase 1, Phase 2]
A Phase 1/2 clinical trial assessing safety, pharmacokinetics and pharmacodynamics of Kamada anti-SARS-CoV-2 therapy in COVID-19 patients ha…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-12-22Clinical Trial Update: Benefit of Clarithromycin in Patients With Severe Infections Through Modulation of the Immune System [Phase 3]
Phase 3 trial update evaluating clarithromycin for severe infections by modulating the immune system in sepsis and pneumonia.
-
CLINICAL_TRIALS withdrawal · 2020-12-21Clinical Trial Update: Aralast NP With Antiviral Treatment and Standard of Care Versus Antiviral Treatment With Standard of Care in Hospitalized Patients With Pneumonia and COVID-19 Infection [Phase 3]
Phase 3 trial comparing Aralast NP with antiviral treatment and standard care versus antiviral treatment with standard care in hospitalized …
-
CLINICAL_TRIALS trial_result · 2020-12-19Clinical Trial Update: Tifacogin for the Treatment of Patients With Severe Community-Acquired Pneumonia [Phase 3]
Phase 3 clinical trial update for tifacogin in severe community-acquired pneumonia has completed.
-
CLINICAL_TRIALS trial_result · 2020-10-26Clinical Trial Update: Safety and Efficiency of Method of Exosome Inhalation in COVID-19 Associated Pneumonia [Phase 2]
Phase 2 clinical trial update on inhaled exosome therapy for COVID-19-associated pneumonia; safety and efficacy data not yet clearly reporte…
-
CLINICAL_TRIALS trial_result · 2020-10-23Clinical Trial Update: Protecting From Pneumococcus in Early Life (The PROPEL Trial) [Phase 3]
Phase 3 clinical trial update focusing on protection from pneumococcus in early life (PROPEL Trial).
-
CLINICAL_TRIALS trial_result · 2020-10-14Clinical Trial Update: Intravenous Immunoglobulin (IVIG, Bioven) Efficacy Assess for COVID-19 / SARS-CoV-2 Severe Pneumonia Complex Treatment [Phase 3]
Phase 3 trial update of IVIG (Bioven) for COVID-19 with severe pneumonia shows completion of the study.
-
CLINICAL_TRIALS trial_result · 2020-08-31Clinical Trial Update: Nebulized Heparin in Severe Acute Respiratory Syndrome COVID-19 [Phase 4]
Phase 4 clinical trial update on nebulized heparin for COVID-19 and pneumonia; current status unknown.
-
CLINICAL_TRIALS trial_result · 2020-05-29Clinical Trial Update: High Versus Low LMWH Dosages in Hospitalized Patients With Severe COVID-19 Pneumonia and Coagulopathy [Phase 3]
A Phase 3 trial comparing high versus low doses of low-molecular-weight heparin in hospitalized patients with severe COVID-19 pneumonia and …
-
FDA label_change · 2020-05-26FDA Approved: ZOSYN IN GALAXY CONTAINERS — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application for ZOSYN in Galaxy containers, a packaging/labeling change for the piperacillin/tazobactam product.…
-
CLINICAL_TRIALS trial_result · 2020-05-13Clinical Trial Update: A Phase III Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants [Phase 3]
Phase III trial update for a 13-valent pneumococcal conjugate vaccine in healthy infants completed.
-
CLINICAL_TRIALS trial_result · 2020-04-28Clinical Trial Update: Efficacy of Captopril in Covid-19 Patients With Severe Acute Respiratory Syndrome (SARS) CoV-2 Pneumonia (CAPTOCOVID) [Phase 2]
Phase 2 trial update evaluating captopril for efficacy in COVID-19 patients with pneumonia (CAPTOCOVID).
-
CLINICAL_TRIALS trial_result · 2020-04-24Clinical Trial Update: Baricitinib Therapy in COVID-19 [Phase 2, Phase 3]
Clinical trial update on baricitinib therapy for COVID-19 with pneumonia conducted in Phase 2 and Phase 3 stages; status completed.
-
CLINICAL_TRIALS trial_result · 2020-04-22Clinical Trial Update: Immunogenicity and Safety Study of 15-Valent Pneumococcal Conjugate Vaccine in 2-month-old and 3-month-old Healthy Volunteers [Phase 3]
Phase 3 trial update assessing immunogenicity and safety of a 15-valent pneumococcal conjugate vaccine in healthy 2- to 3-month-old infants.
-
CLINICAL_TRIALS trial_result · 2020-04-13Clinical Trial Update: Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19 [Phase 3]
Phase 3 trial update on hydroxychloroquine for COVID-19 shows efficacy and safety data from completed study.
-
CLINICAL_TRIALS trial_result · 2020-04-13Clinical Trial Update: Efficacy and Safety of Darunavir and Cobicistat for Treatment of COVID-19 [Phase 3]
Phase 3 trial update on the efficacy and safety of darunavir with cobicistat for COVID-19 pneumonia.
-
CLINICAL_TRIALS trial_result · 2020-03-11Clinical Trial Update: Evaluation of Implementation of a National Point-of-Care Ultrasound Training Program
A completed clinical trial assessing the implementation of a national point-of-care ultrasound training program and its effects on various a…
-
CLINICAL_TRIALS trial_result · 2020-02-25Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Pirfenidone With Novel Coronavirus Infection [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of pirfenidone for novel coronavirus pneumonia/pneumonia is in unknown status.
-
CLINICAL_TRIALS trial_result · 2020-02-20Clinical Trial Update: Immunogenicity and Safety of 23-Valent Pneumococcal Polysaccharide Vaccine in Healthy Volunteers Aged 2 Years and Above [Phase 3]
Phase 3 trial assessing immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccine in healthy volunteers aged 2 years and …
-
CLINICAL_TRIALS trial_result · 2020-02-18Clinical Trial Update: Efficacy and Safety of Rheosorbilact® Solution for Infusion, in a Complex Therapy of Pneumonia [Phase 4]
Phase 4 trial update evaluating efficacy and safety of Rheosorbilact Solution for Infusion as part of pneumonia therapy.
-
EMA withdrawal · 2020-02-05EMA Application withdrawn: Nuzyra — Paratek Ireland Limited
The EMA status shows withdrawal of the Nuzyra application by Paratek Ireland Limited.